Navigation Links
Singulex and Thermo Fisher Scientific Enter into License and Supply Agreement to bring Next Generation Immunodiagnostics to Sepsis and SIRS Diagnostics
Date:12/8/2016

ALAMEDA, Calif., Dec. 8, 2016 /PRNewswire-USNewswire/ -- Singulex, Inc., the leader in Next Generation Immunodiagnostics powered by Single Molecule Counting technology, entered into a license and supply agreement with Thermo Fisher Scientific, the world leader in serving science. The agreement provides Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker which, in Europe is used to diagnose systemic bacterial infection and sepsis and in the United States to aid in assessing the risk of critically ill patients for progression to severe sepsis and septic shock, and the risk of mortality in patients diagnosed with sepsis. Sepsis and systemic inflammatory response syndrome (SIRS) are potentially life-threatening complications of infection which can bring significant health and economic cost if not identified and treated early.

Singulex is utilizing their proprietary Single Molecule Counting technology to develop a sepsis and SIRS rule-out and rule-in test using the Procalcitonin biomarker for the Sgx Clarity system. The Sgx Clarity System, currently in development and not yet approved for sale, is a fully automated, Next Generation Immunodiagnostics platform designed to bring the benefits of Singulex's SMC™ technology to hospital and reference labs worldwide.

"The agreement with Thermo Fisher marks an important milestone in the diagnosis and treatment of sepsis and SIRS, a significant global health concern," said Guido Baechler, president and chief executive officer, Singulex. "It is also another validation of the power of Singulex's Next Generation Immunodiagnostics platform powered by SMC. Building on our proven success in cardiac troponin diagnostic analysis, our plan is to develop and commercialize sepsis and SIRS rule-out and rule-in tests for use on our Sgx Clarity System. The combination of SMC-powered utility designed in the Sgx Clarity System with the proven Thermo Scientific BRAHMS PCT know-how and biomaterials will be a major advancement for the medical community."

SMC is proven to be more than a hundred times more sensitive than currently available assay technology. This unprecedented sensitivity is designed to bring greater utility to identify sepsis and SIRS and potentially enable earlier disease detection. Earlier and more confident detection and diagnosis benefits both patient outcomes and helps reduce healthcare cost. According to the U.S. Agency for Healthcare Research and Quality, sepsis is considered the most expensive condition treated in the United States, costing more than $23 billion USD in 2013, and rising[1].  

Thermo Fisher Scientific is a recognized leader in serving science and developing biomarkers which guide the diagnosis and management of disease. Their BRAHMS PCT biomarker is a breakthrough in the field of sepsis diagnosis. Application of SMC technology with the BRAHMS PCT biomarker will allow the identification of Procalcitonin at levels previously unachievable.

The unprecedented sensitivity and utility of Singulex's SMC technology is designed to aid physicians with earlier and more confident identification of this potentially life-threatening condition. By identifying biomarker levels with greater sensitivity than currently available tests, physicians may detect disease earlier, a critical step for patients particularly those in emergency rooms, intensive care or neonatal intensive care units.

About Singulex, Inc.
Singulex is the next generation immunodiagnostic company developing Single Molecule Counting technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMCTM technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultrasensitive lab testing services are transforming patient care from reactive disease treatment to proactive health management.

[1] National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013, Celeste M. Torio, Ph.D., M.P.H., and Brian J. Moore, Ph.D. May 2016; https://www.hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hospital-Conditions.jsp 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/singulex-and-thermo-fisher-scientific-enter-into-license-and-supply-agreement-to-bring-next-generation-immunodiagnostics-to-sepsis-and-sirs-diagnostics-300374750.html


'/>"/>
SOURCE Singulex, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related biology news :

1. Research and Markets - Global Bioinformatics Market to Reach $16.18 Billion by 2021 - Key Vendors are Illumina, Qiagen & Thermo Fisher Scientific
2. Water thermostat could help engineer drought-resistant crops
3. Dynamic culture of a thermosensitive collagen hydrogel improves tissue-engineered peripheral nerve
4. Synthetic genetic clock checks the thermometer
5. When calculating cell-growth thermodynamics, reconsider using the Gibbs free energy equation
6. A look at Floridas charterboat-based recreational shark fishery
7. Shift in Arabia sea plankton may threaten fisheries
8. Study shows Asian carp could establish in Lake Erie with little effect to fishery
9. Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel
10. Changes in forage fish abundance alter Atlantic cod distribution, affect fishery success
11. Report supports shutdown of all high seas fisheries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2018)... N.C. (PRWEB) , ... October 05, 2018 , ... ... Nutrition North America, Inc. (AHN), is announcing a 10% price increase across all ... AHN produces amino acids — the building blocks of protein — for the ...
(Date:10/5/2018)... ... ... Nothing brings a team together like cooking and eating does, which is ... to companies because it encourages a range of healthy activities that can translate into ... also appealing in that everyone – no matter their culinary ability – can participate. ...
(Date:10/2/2018)... ... , ... Through this webinar, sponsored by Molecular Devices , participants will ... role of calcium kinetics in cardiac safety testing. The speakers for this event will ... Tsang Wai Lam, an assay development scientist at PPSC. , They will discuss how ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... Ohio (PRWEB) , ... October 02, 2018 , ... ... announced, and Locus Bio-Energy Solutions™, LLC’s (Locus Bio-Energy) AssurEOR product line was chosen ... World Oil and Gulf Energy Information, honor leading innovations in upstream oil applications ...
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. has announced a ... GlycoMark test, the only FDA-cleared blood test specific to detecting recent hyperglycemia and ... offer the GlycoMark test to its network of physicians through its sales organization ...
(Date:9/27/2018)... BOSTON (PRWEB) , ... September 26, 2018 , ... ... conference. Medable is a platform that aims to build the first human digitome, ... clinical trial and real-world data through a seamless integration of all data sources. ...
(Date:9/24/2018)... ... , ... ReGrow Helmet , the most advanced laser hair treatment device, ... hair regrowth in the comfort of one’s home. Early campaign backers will save 40% ... sophisticated design and advanced technology of the ReGrow Helmet will lead the industry in ...
Breaking Biology Technology: